Anebulo Pharmaceuticals, Inc. (ANEB) Tops Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts ANEB Hot Sheet
Join SI Premium – FREE
Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported Q3 EPS of ($0.04), $0.04 better than the analyst estimate of ($0.08).
For earnings history and earnings-related data on Anebulo Pharmaceuticals, Inc. (ANEB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Simply Good Foods (SMPL) Tops Q3 EPS by 7c; offers outlook
- Meta to begin manufacturing 'Iris' AI chip in September - Reuters
- Simply Good Foods posts Q3 loss, cuts fiscal 2026 outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
